medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2017, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2017; 15 (2)

Phototherapy in the Biologic’s Therapy Era. Still Efective?

Pérez-Madrid C, Chiquito-García S, Uribe-Bojanini E, Jiménez-Tamayo SE

Language: Spanish
References: 58
Page: 114-121
PDF size: 144.82 Kb.


ABSTRACT

Phototherapy is a therapy widely used in patients with psoriasis. Its effectiveness has been proven by the reduction of PASI (psoriasis area severity index) and the results are comparable to those achieved with other therapies more expensive and with more adverse effects. The aim of this review is to emphasize the benefits, indications and contraindications of phototherapy, which is a cost-effect treatment, which can be used as monotherapy or in combination with other topical and/or systemic therapy. Currently they have been dabbling new technologies, despite this, phototherapy is still a relevant and treatment that its use should be indicated more frequently.


REFERENCES

  1. González C, Londoño A y Castro L (eds.), Guías basadas en la evidencia para el manejo de la psoriasis en Colombia, Bogotá, Panamericana, 2012.

  2. Vaño-Galvann S, Garate MT, Fleta-Asinn B et al., Análisis coste-efectividad de la fototerapia domiciliaria con ultravioleta B de banda estrecha frente a fármacos biológicos en el tratamiento de la psoriasis moderada- grave, Actas Dermosifiliogr 2012; 103(2): 127-37.

  3. Hung R, Ungureanu S, Edwards C et al., Home phototherapy for psoriasis: a review and update, Clin Exp Dermatol 2015; 40(8): 827-33.

  4. Inzinger M, Heschl B, Weger W et al., Efficacy of psoralen plus ultraviolet. A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry, Br J Dermatol 2011; 165(3): 640-5.

  5. Beyer V y Wolverton SE, Recent trends in systemic psoriasis treatment costs, Arch Dermatol 2010; 146(1): 46-54.

  6. Hönigsmann H, History of phototherapy in dermatology, Photochem Photobiol Sci 2012; 12(1): 16-21.

  7. Racz E y Prens EP, Phototherapy and photochemotherapy for psoriasis, Dermatol Clin 2015; 33(1) :79-89.

  8. Kragballe K, Hölzle E Van de Kerkhof PCM y Philipp S, Treatment of plaque psoriasis, en Psoriasis: diagnosis and management, 2015, pp. 163-213.

  9. Chen X, Yang M, Cheng Y et al., Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet A or psoralen-ultraviolet A photochemotherapy for psoriasis, Cochrane Database Syst Rev, 2013.

  10. Martínez M, Levrero P, Carusso R y Morales C, Psoriasis vulgar moderada y severa: opciones terapéuticas (tratamientos convencionales), Arch Med Interna 2013; 35(3): 93-100.

  11. Totonchy MB y Chiu MW, UV-based therapy, Dermatol Clin 2014; 32(3): 399-413.

  12. Ubogui JG y Saposnik M, Fototerapia ultravioleta en dermatología, Dermatol Argent 2008; 4(4): 267-75.

  13. Coimbra S, Oliveira H, Reis F et al., Interleukin IL-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy, Br J Dermatol 2010; 163(6): 1282-90.

  14. Batycka-Baran A, Besgen P, Wolf R et al., The effect of phototherapy on systemic inflammatory process in patients with plaque psoriasis, J Photochem Photobiol B Biol 2016; 161: 396-401.

  15. Meola T, Soter NA y Lim HW, Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature, Arch Dermatol 1991; 127(11): 1708-13.

  16. Menter A, Korman NJ, Elmets CA et al., Guidelines of care for the management of psoriasis and psoriatic arthritis: section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy, J Am Acad Dermatol 2010; 62(1): 114-35.

  17. Menter MA, See JA, Amend WJ et al., Proceedings of the psoriasis combination and rotation therapy conference, Deer Valley, Utah, 7-9 de octubre de 1994, J Am Acad Dermatol 1996; 34(2 Pt 1): 315-21.

  18. Ramsay CA, Schwartz BE, Lowson D et al., Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and uvb-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group, Dermatology 2000; 200(1): 17-24.

  19. Ashcroft DM, Li Wan Po A, Williams HC y Griffiths CE, Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability, Arch Dermatol 2000; 136(12): 1536-43.

  20. Nast A, Boehncke WH, Mrowietz U et al., German S3-guidelines on the treatment of psoriasis vulgaris (short version), Arch Dermatol Res 2012; 304(2): 87-113.

  21. Torras H, Aliaga A, López-Estebaranz JL et al., A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris, J Dermatolog Treat 2004; 15(2): 98-103.

  22. Koo JY, Lowe NJ, Lew-Kaya DA et al., Tazarotene plus UVB phototherapy in the treatment of psoriasis, J Am Acad Dermatol 2000; 43(5 Pt 1): 821-8.

  23. Tzaneva S, Hönigsmann H, Tanew A y Seeber A, A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis, Br J Dermatol 2002; 147(4): 748-53.

  24. Asawanonda P y Nateetongrungsak Y, Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebocontrolled study, J Am Acad Dermatol, 2006, 54(6): 1013-1018.

  25. Ozdemir M, Engin B, Baysal I et al., A randomized comparison of acitretin-narrow-band TL -01 phototherapy and acitretin-psoralen plus ultraviolet a for psoriasis, Acta Derm Venereol 2008; 88(6): 589-93.

  26. Menter A, Korman N, Elmets C et al., Guidelines of care for the management of psoriasis and psoriatic arthritis, J Am Dermatology 2009; 60(4): 643-59, disponible en: http://dx.doi.org/10.1016/j. jaad.2008.12.032.

  27. Nijsten TEC y Stern RS, Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen- UVA: a nested cohort study, J Am Acad Dermatol 2003; 49(4): 644-50.

  28. Kircik L, Bagel J, Korman N et al., Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes, J Drugs Dermatol 2008; 7(3): 245-53.

  29. Calzavara-Pinton PG, Sala R, Arisi M et al., Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis, Br J Dermatol 2013; 169(1): 130-6.

  30. Wolf P, Weger W, Legat FJ et al., Treatment with 311-nm ultraviolet b enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial, Br J Dermatol 2012; 166(1): 147-53.

  31. Naldi L, Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies, Clin Dermatol 2010; 28(1): 88-92.

  32. Wolfe F y Michaud K, Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study, Arthritis Rheum 2007; 56(9): 2886-95.

  33. Sigurdardottir G, Ekman AK, Ståhle M et al., Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis, J Am Acad Dermatol 2014; 70(6): 1067-75.

  34. Dujic J, Kippenberger S, Hoffmann S et al., Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light, J Invest Dermatol 2007; 127(8): 1992-2000.

  35. Dujic J, Kippenberger S, Ramírez-Bosca A et al., Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model, Int J Cancer 2009; 124(6): 1422-1428.

  36. Carrión-Gutiérrez M, Ramírez-Bosca A, Navarro-López V et al., Effects of curcuma extract and visible light on adults with plaque psoriasis, Eur J Dermatol 2015; 25(3): 240-6.

  37. Lim HW, Silpa-Archa N, Amadi U et al., Phototherapy in dermatology: a call for action, J Am Acad Dermatol 2015; 72(6): 1078-80.

  38. Kawada A, Evolution of targeted phototherapy for psoriasis, Expert Rev Dermatol 2013; 8(6): 623-9.

  39. Goldinger SM, Dummer R, Schmid P et al., Excimer laser versus narrow- band UVB (311 nm) in the treatment of psoriasis vulgaris, Dermatology 2006; 213(2): 134-9.

  40. Almutawa F, Thalib L, Hekman D et al., Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis, Photodermatol Photoimmunol Photomed 2015; 31(1): 5-14.

  41. Beggs S, Short J, Rengifo-Pardo M y Ehrlich A, Applications of the excimer laser: a review, Dermatol Surg 2015; 41(11): 1201-11.

  42. Lapolla W, Yentzer BA, Bagel J et al., A review of phototherapy protocols for psoriasis treatment, J Am Acad Dermatol 2011; 64: 936-49.

  43. Berneburg M, Röcken M y Benedix F, Phototherapy with narrowband vs broadband UVB, Acta Dermato-Venereol 2005; 85: 98-108.

  44. Osorio F y Magina S, Phototherapy and photopheresis: old and new indications, Expert Rev Dermatol 2011; 6(6): 613-23.

  45. Gerber W, Arheilger B, Ha TA et al., Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach, Br J Dermatol 2003; 149(6): 1250-8.

  46. Bónis B, Kemény L, Dobozy A et al., 308 nm UVB excimer laser for psoriasis, Lancet 1997; 350(9090): 1522.

  47. Köllner K, Wimmershoff MB, Hintz C et al., Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis, Br J Dermatol 2005; 152(4): 750-4.

  48. Stein KR, Pearce DJ y Feldman SR, Targeted UV therapy in the treatment of psoriasis, J Dermatolog Treat 2008; 19(3): 141-5.

  49. Bianchi B, Campolmi P, Mavilia L et al., Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis, J Eur Acad Dermatol Venereol 2003; 17(4): 408-13.

  50. Kagen M, Cao LY, Oyetakin-White P et al., Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis, Photodermatol Photoimmunol Photomed 2012; 28(6): 293-8.

  51. Anderson KL y Feldman SR, A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles, J Am Acad Dermatol 2015; 72(5): 868-78.e1.

  52. Bhutani T y Liao W, A practical approach to home UVB phototherapy for the treatment of generalized psoriasis, Pract dermatology 2010; 7(2): 31-5.

  53. Sarkany R, Anstey A, Diffey B et al., Home phototherapy: report on a workshop of the British Photodermatology Group, December 1996, Br J Dermatol 1999; 140(2): 195-9.

  54. Koek MBG, Buskens E, Van Weelden H et al., Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study), BMJ 2009; 338: b1542.

  55. Franken SM, Witte BI, Pavel S y Rustemeyer T, Psoriasis and daily low-emission phototherapy: effects on disease and vitamin D level, Photodermatol Photoimmunol Photomed 2015; 31(2): 83-9.

  56. Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA et al., Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study, J Am Acad Dermatol 2012; 67(5): 931-8.

  57. Guilhou JJ, Colette C, Monpoint S et al., Vitamin D metabolism in psoriasis before and after phototherapy, Acta Derm Venereol 1990; 70(4): 351-4, disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1977266.

  58. Jing S, Photonic fabric devices for phototherapy shen. Handbook of smart textiles, 2014.




2020     |     www.medigraphic.com